A Study to Investigate the Pharmacokinetics of AZD2389 when Administered Alone and in Combination with Itraconazole in Healthy Participants

Trial Identifier: D7930C00005
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: February 2025
Primary Completion Date: April 2025
Study Completion Date: April 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225